ISRG / Intuitive Surgical, Inc. (NasdaqGS) - Forecast, Price Target, Estimates, Predictions

Intuitive Surgical, Inc.
US ˙ NasdaqGS ˙ US46120E6023

Projected Stock Price
$597.45 ↑27.97%

Estimated share price by September 2, 2026.

Projected Revenue

2,868  MM ↑17.54%

Estimated quarterly revenue by December 31, 2026.

Projected Earnings Per Share

3.43 ↑86.61%

Estimated quarterly earnings by December 31, 2027.

Price Target

The average one-year price target for Intuitive Surgical, Inc. is $597.45. The forecasts range from a low of $444.40 to a high of $719.25.

Update Frequency: Monthly

Record Date Projection Date High Low Median Average
2025-09-02 2026-09-02 719.25 444.40 606.71 597.45
Stock Upgrades/Downgrades

This card shows analyst upgrades/downgrades for Intuitive Surgical, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.

The standard analyst ratings are generally as follows:
  • Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
  • Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
  • Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.

When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.

The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.

Why Are Analyst Ratings important?

In addition to being able to interpret financial data, stock analysts have connections within the companies they cover that give them access to information retail investors do not have.

Therefore, analyst ratings can help you find opportunities in the market. However, they are guidelines more than recommendations. This is why it’s important to look at analyst ratings over a period of time.

If analysts change their ratings frequently, you should pay close attention to the company’s fundamentals. For example, has there been a significant change to the company’s earnings growth and/or debt?

You should also pay attention to the number of analysts covering a stock over the course of a year. In general, the more analysts who cover the stock give the consensus rating more credibility, but each individual rating less overall weight.

How to Use Analyst Ratings ?

Analyst ratings are one data point for you to consider. Here are some strategies you can use to fine tune your research.

Look at more than one analyst and don’t hesitate to look at analysts that have differing views. This can help challenge any preconceived ideas you have about a stock and point out ways in which your thesis for owning or avoiding a stock may have changed.

Compare a stock’s rating with other stocks in its industry or sector. In some cases, a stock is simply superior to others in its sector. However, at other times, it could be overvalued based on investor sentiment instead of fundamentals.

How are the Fintel Analyst Ratings different?

Analyst ratings by Fintel are presented in close to real-time to stay ahead of generalized information flow. Combined with target price estimates and revenue estimates for the company you have greater accuracy despite market volatility.

Date Analyst Prior Latest
Recommendation
Action
2022-12-22 Argus Research Buy Maintains
2022-12-20 Truist Securities Buy Maintains
2022-12-12 Wells Fargo Overweight Maintains
2022-12-05 BTIG Buy Maintains
2022-11-18 JP Morgan Overweight Maintains
2022-10-20 Deutsche Bank Hold Maintains
2022-10-19 Wells Fargo Overweight Maintains
2022-10-19 Truist Securities Buy Maintains
2022-10-19 Piper Sandler Overweight Maintains
2022-10-19 Morgan Stanley Equal-Weight Maintains
2022-10-18 Barclays Overweight Initiate
2022-10-17 Truist Securities Buy Maintains
2022-10-13 Mizuho Neutral Initiate
2022-10-12 Jefferies Hold Initiate
2022-10-11 Morgan Stanley Equal-Weight Maintains
2022-09-09 Stifel Buy Maintains
2022-08-18 Piper Sandler Overweight Maintains
2022-07-22 Truist Securities Buy Maintains
2022-07-22 RBC Capital Outperform Maintains
2022-07-22 Raymond James Outperform Maintains
2022-07-22 Piper Sandler Overweight Maintains
2022-07-22 Deutsche Bank Hold Maintains
2022-07-22 Citigroup Buy Maintains
2022-07-18 Stifel Buy Maintains
2022-07-18 BTIG Buy Maintains
2022-07-15 Raymond James Outperform Maintains
2022-07-15 Morgan Stanley Equal-Weight Maintains
2022-07-13 Truist Securities Buy Maintains
2022-06-22 Deutsche Bank Hold Maintains
2022-05-17 Citigroup Buy Maintains
2022-04-25 Morgan Stanley Equal-Weight Maintains
2022-04-22 Wells Fargo Overweight Maintains
2022-04-22 Raymond James Outperform Maintains
2022-04-22 Piper Sandler Overweight Maintains
2022-04-13 Truist Securities Buy Initiate
2022-04-06 Wolfe Research Peer Perform Initiate
2022-03-25 RBC Capital Outperform Initiate
2022-02-02 UBS Neutral Buy Upgrade
2022-01-31 Piper Sandler Neutral Overweight Upgrade
2022-01-25 Redburn Partners Buy Neutral Downgrade
2022-01-21 Wells Fargo Overweight Maintains
2022-01-21 Raymond James Outperform Maintains
2022-01-21 Piper Sandler Neutral Maintains
2022-01-21 Morgan Stanley Equal-Weight Maintains
2022-01-21 Deutsche Bank Hold Maintains
2022-01-21 Citigroup Neutral Buy Upgrade
2022-01-10 BTIG Neutral Buy Upgrade
2022-01-07 Morgan Stanley Equal-Weight Maintains
2021-10-21 Morgan Stanley Equal-Weight Maintains
2021-10-20 Wells Fargo Overweight Maintains
2021-10-05 Morgan Stanley Equal-Weight Maintains
2021-10-01 Citigroup Buy Neutral Downgrade
2021-08-26 SVB Leerink Market Perform Maintains
2021-07-22 Deutsche Bank Hold Maintains
2021-07-21 Wells Fargo Overweight Maintains
2021-07-21 Morgan Stanley Equal-Weight Maintains
2021-07-21 Evercore ISI Group In-Line Maintains
2021-07-21 Citigroup Buy Maintains
2021-07-20 SVB Leerink Market Perform Maintains
2021-07-14 Stifel Buy Maintains
2021-06-07 Wells Fargo Overweight Maintains
2021-06-01 Evercore ISI Group Underperform In-Line Upgrade
2021-05-24 Argus Research Buy Maintains
2021-04-21 SVB Leerink Market Perform Maintains
2021-04-21 Piper Sandler Neutral Maintains
2021-04-21 Oppenheimer Underperform Perform Upgrade
2021-04-21 Morgan Stanley Equal-Weight Maintains
2021-04-21 Deutsche Bank Hold Maintains
2021-04-21 Citigroup Buy Maintains
2021-04-21 Baird Neutral Outperform Upgrade
2021-04-01 Citigroup Buy Initiate
2021-03-31 Piper Sandler Neutral Maintains
2021-01-22 Raymond James Outperform Maintains
2020-12-15 Morgan Stanley Overweight Equal-Weight Downgrade
2020-10-16 Wells Fargo Overweight Maintains
2020-10-16 SVB Leerink Market Perform Maintains
2020-10-16 Morgan Stanley Overweight Maintains
2020-10-12 Raymond James Outperform Maintains
2020-09-28 Argus Research Buy Initiate
2020-09-11 Wolfe Research Outperform Initiate
2020-09-08 B of A Securities Buy Neutral Downgrade
2020-09-02 Baird Neutral Initiate
2020-08-14 SVB Leerink Market Perform Maintains
2020-07-22 Wells Fargo Overweight Maintains
2020-07-22 UBS Neutral Maintains
2020-07-22 SVB Leerink Market Perform Maintains
2020-07-22 Stifel Buy Maintains
2020-07-22 Raymond James Outperform Maintains
2020-07-22 Morgan Stanley Overweight Maintains
2020-07-22 Deutsche Bank Hold Maintains
2020-07-22 Canaccord Genuity Buy Maintains
2020-07-15 SVB Leerink Market Perform Maintains
2020-06-18 JP Morgan Overweight Maintains
2020-06-04 Wells Fargo Overweight Maintains
2020-04-28 Piper Sandler Overweight Neutral Downgrade
2020-04-17 Wells Fargo Overweight Maintains
2020-04-17 UBS Neutral Maintains
2020-04-17 SVB Leerink Outperform Market Perform Downgrade
2020-04-17 Deutsche Bank Hold Maintains
2020-04-17 Canaccord Genuity Buy Maintains
2020-04-13 Raymond James Outperform Maintains
2020-04-09 Evercore ISI Group In-Line Underperform Downgrade
2020-04-02 Wells Fargo Overweight Maintains
2020-04-01 Oppenheimer Perform Underperform Downgrade
2020-03-27 Morgan Stanley Overweight Maintains
2020-03-24 Stifel Buy Maintains
2020-03-17 JP Morgan Overweight Maintains
2020-02-13 Goldman Sachs Buy Initiate
2020-01-27 Deutsche Bank Buy Hold Downgrade
2020-01-24 Raymond James Outperform Maintains
2020-01-24 JP Morgan Overweight Maintains
2020-01-10 UBS Neutral Maintains
2020-01-10 Cantor Fitzgerald Overweight Reiterate
2019-12-17 Morgan Stanley Overweight Maintains
2019-11-29 First Shanghai Buy Initiate
2019-11-21 Oppenheimer Perform Initiate
2019-10-18 UBS Neutral Maintains
2019-07-19 Canaccord Genuity Buy Maintains
2019-05-14 Citigroup Buy Maintains
2019-04-23 Citigroup Buy Buy Maintains
2019-04-22 Raymond James Outperform Outperform Maintains
2019-04-22 Canaccord Genuity Buy Buy Maintains
2019-04-02 Deutsche Bank Buy Initiate
2019-04-01 Raymond James Outperform Outperform Maintains
2019-01-02 Citigroup Buy Buy Maintains
2018-11-29 Citigroup Buy Buy Maintains
2018-11-28 UBS Neutral Initiate
2018-10-19 Raymond James Outperform Outperform Maintains
2018-10-19 Canaccord Genuity Hold Buy Upgrade
2018-10-11 Morgan Stanley Overweight Overweight Maintains
2018-10-10 PiperJaffray Neutral Overweight Upgrade
2018-10-09 PiperJaffray Neutral Overweight Upgrade
2018-09-12 Wells Fargo Outperform Outperform Maintains
2018-08-02 Citigroup Buy Buy Maintains
2018-07-20 Stifel Nicolaus Buy Buy Maintains
2018-07-20 Morgan Stanley Overweight Overweight Maintains
2018-07-17 Bank of America Buy Buy Maintains
2018-06-27 Bernstein Outperform Initiate
2018-06-01 Morgan Stanley Overweight Overweight Maintains
2018-04-18 Stifel Nicolaus Buy Buy Maintains
2018-04-18 Morgan Stanley Overweight Overweight Maintains
2018-04-18 Canaccord Genuity Hold Hold Maintains
2018-04-18 Bank of America Buy Buy Maintains
2018-02-06 Citigroup Buy Buy Maintains
2018-01-26 Stifel Nicolaus Buy Buy Maintains
2018-01-26 Morgan Stanley Overweight Overweight Maintains
2018-01-26 Canaccord Genuity Hold Hold Maintains
2018-01-26 Barclays Overweight Overweight Maintains
2018-01-03 Evercore ISI Group In-Line Initiate
2017-10-23 Citigroup Buy Maintains
2017-10-20 Morgan Stanley Overweight Maintains
2017-10-20 Barclays Overweight Maintains
2017-07-25 Morgan Stanley Overweight Maintains
2017-06-30 Cantor Fitzgerald Neutral Initiate
2017-05-16 Goldman Sachs Buy Initiate
2017-01-04 Evercore ISI Group Buy Hold Downgrade
2016-10-13 Wells Fargo Outperform Initiate
2016-08-26 Raymond James Outperform Initiate
2016-07-20 Citigroup Buy Maintains
2016-07-20 Barclays Overweight Maintains
2016-06-02 Goldman Sachs Buy Neutral Downgrade
2016-04-20 Bank of America Buy Maintains
2016-04-01 BTIG Research Buy Neutral Downgrade
2016-01-04 Morgan Stanley Equal-Weight Overweight Upgrade
2015-11-12 Citigroup Buy Initiate
2015-07-22 Canaccord Genuity Buy Upgrade
2015-07-22 Barclays Overweight Maintains
2015-07-06 Morgan Stanley Equal-Weight Underweight Downgrade
2015-06-25 Barclays Overweight Initiate
2015-05-12 PiperJaffray Neutral Initiate
2015-01-05 Jefferies Buy Maintains
2015-01-02 Bank of America Buy Maintains
2014-10-22 Northland Securities Underperform Market Perform Upgrade
2014-10-22 BTIG Research Neutral Buy Upgrade
2014-10-17 Leerink Swann Market Perform Outperform Upgrade
2014-10-06 Goldman Sachs Neutral Buy Upgrade
2014-09-22 RBC Capital Sector Perform Initiate
2014-07-23 Stifel Nicolaus Hold Buy Upgrade
2014-07-23 Raymond James Market Perform Outperform Upgrade
2014-07-23 JP Morgan Overweight Maintains
2014-07-08 BTIG Research Neutral Initiate
2014-04-29 Sterne Agee Underperform Neutral Upgrade
2014-04-23 SunTrust Robinson Humphrey Buy Maintains
2014-04-23 Sterne Agee Underperform Maintains
2014-04-23 Leerink Swann Market Perform Maintains
2014-04-23 JP Morgan Overweight Maintains
2014-04-23 Canaccord Genuity Hold Maintains
2014-04-14 Leerink Swann Market Perform Maintains
2014-04-09 Sterne Agee Underperform Initiate
2014-04-08 Sterne Agee Underperform Initiate
2014-04-02 JMP Securities Market Underperform Market Outperform Upgrade
2014-04-02 Bank of America Buy Maintains
2014-04-01 JP Morgan Overweight Maintains
2014-03-04 Cantor Fitzgerald Buy Hold Downgrade
2014-01-21 ISI Group Strong Buy Initiate
2013-12-05 Jefferies Buy Initiate
2013-11-26 CRT Capital Sell Initiate
2013-11-25 CRT Capital Sell Initiate
2013-10-18 Northland Market Perform Underperform Downgrade
2013-09-03 First Analysis Equal-Weight Underweight Downgrade
2013-07-19 Northland Securities Underperform Market Perform Upgrade
2013-07-19 JMP Securities Market Perform Market Underperform Downgrade
2013-07-09 Raymond James Outperform Market Perform Downgrade
2013-07-09 JMP Securities Market Outperform Market Perform Downgrade
2013-07-09 Goldman Sachs Buy Neutral Downgrade
2013-07-09 Canaccord Genuity Buy Hold Downgrade
2013-07-09 Ameriprise Financial Buy Sell Downgrade
2013-06-25 First Analysis Equal-Weight Initiate
2013-06-18 Wedbush Outperform Initiate
2013-06-17 Wedbush Outperform Initiate
2013-03-18 Canaccord Genuity Hold Buy Upgrade
2013-03-05 Northland Underperform Initiate
2013-03-01 Cantor Fitzgerald Hold Buy Upgrade
2013-02-22 Goldman Sachs Neutral Buy Upgrade
2013-01-23 Cantor Fitzgerald Hold Maintains
2013-01-18 Janney Capital Buy Initiate
2013-01-17 Janney Capital Buy Initiate
2013-01-16 Goldman Sachs Neutral Maintains
2013-01-14 Lazard Neutral Buy Upgrade
2012-12-04 Cantor Fitzgerald Hold Maintains
2012-11-20 Stifel Nicolaus Hold Initiate
2012-10-31 Barrington Research Market Perform Outperform Upgrade
2012-10-19 Bank of America Neutral Buy Upgrade
2012-10-15 JP Morgan Neutral Overweight Upgrade
2012-08-27 Goldman Sachs Neutral Maintains
2012-07-25 Mizuho Neutral Buy Upgrade
2012-05-30 JP Morgan Neutral Maintains
2012-04-18 JP Morgan Neutral Maintains
2012-04-18 Goldman Sachs Neutral Maintains
2012-04-18 Dougherty Buy Maintains
2012-04-18 Cantor Fitzgerald Hold Maintains
2012-04-10 Dougherty Buy Initiate
2023-01-06 Morgan Stanley Equal-Weight Maintains
2023-01-26 Raymond James Outperform Maintains
2023-01-24 Mizuho Neutral Maintains
2023-01-25 Wells Fargo Overweight Maintains
2023-01-25 Truist Securities Buy Maintains
2023-01-25 Morgan Stanley Equal-Weight Maintains
2023-01-25 Mizuho Neutral Maintains
2023-01-25 Citigroup Buy Maintains
2023-01-25 BTIG Buy Maintains
2023-03-23 William Blair Outperform Initiate
2023-03-29 UBS Neutral Initiate
2023-04-04 Evercore ISI Group In-Line Maintains
2023-04-20 Bernstein Outperform Maintains
2023-04-20 Barclays Overweight Maintains
2023-04-19 BTIG Buy Maintains
2023-04-19 Evercore ISI Group In-Line Maintains
2023-04-19 Piper Sandler Overweight Maintains
2023-04-19 Deutsche Bank Hold Maintains
2023-04-19 Stifel Buy Maintains
2023-04-17 BTIG Buy Maintains
2023-04-19 Wells Fargo Overweight Maintains
2023-04-19 Mizuho Neutral Maintains
2023-04-19 Citigroup Buy Maintains
2023-04-19 Truist Securities Buy Maintains
2023-04-19 B of A Securities Buy Maintains
2023-04-19 Raymond James Outperform Maintains
2023-04-18 Mizuho Neutral Maintains
2023-04-19 Morgan Stanley Equal-Weight Maintains
2023-04-19 RBC Capital Outperform Maintains
2023-04-19 JP Morgan Overweight Maintains
2023-04-24 RBC Capital Outperform Reiterate
2023-05-18 Truist Securities Buy Buy Maintains
2023-05-31 Morgan Stanley Equal-Weight Equal-Weight Maintains
2023-05-31 Bernstein Outperform Outperform Maintains
2023-06-05 BTIG Buy Buy Maintains
2023-07-11 Citigroup Buy Buy Maintains
2023-07-24 Morgan Stanley Equal-Weight Equal-Weight Maintains
2023-07-24 Barclays Overweight Overweight Maintains
2023-07-24 Raymond James Outperform Outperform Maintains
2023-07-12 RBC Capital Outperform Outperform Maintains
2024-01-25 Mizuho Neutral Neutral Maintains
2023-07-21 JP Morgan Overweight Overweight Maintains
2023-07-21 Piper Sandler Overweight Overweight Maintains
2023-07-21 RBC Capital Outperform Outperform Maintains
2023-07-21 Wells Fargo Overweight Overweight Maintains
2023-08-17 RBC Capital Outperform Outperform Reiterate
2023-10-16 Leerink Partners Outperform Initiate
2023-12-22 Truist Securities Buy Buy Maintains
2023-11-17 HSBC Buy Initiate
2024-03-15 Stifel Buy Buy Reiterate
2023-07-19 Truist Securities Buy Buy Maintains
2023-07-19 Baird Outperform Outperform Initiate
2023-10-20 Wells Fargo Overweight Overweight Maintains
2023-10-20 Citigroup Buy Buy Maintains
2023-10-20 RBC Capital Outperform Outperform Reiterate
2023-10-20 Piper Sandler Overweight Overweight Maintains
2023-10-20 Raymond James Outperform Outperform Maintains
2023-12-04 Morgan Stanley Equal-Weight Equal-Weight Maintains
2023-11-17 Stifel Buy Buy Maintains
2023-10-23 Morgan Stanley Equal-Weight Equal-Weight Maintains
2023-12-12 Truist Securities Buy Buy Maintains
2024-01-24 Truist Securities Buy Buy Maintains
2024-01-24 Stifel Buy Buy Maintains
2024-01-24 RBC Capital Outperform Outperform Maintains
2024-01-24 Piper Sandler Overweight Overweight Maintains
2024-04-19 Jefferies Hold Hold Maintains
2024-04-19 BTIG Buy Buy Maintains
2024-04-19 Piper Sandler Overweight Overweight Maintains
2024-04-19 Baird Outperform Outperform Maintains
2024-01-25 Raymond James Outperform Outperform Maintains
2024-01-19 Wells Fargo Overweight Overweight Maintains
2024-01-12 RBC Capital Outperform Outperform Maintains
2024-04-08 Stifel Buy Buy Maintains
2024-01-03 Raymond James Outperform Outperform Maintains
2024-01-25 Barclays Overweight Overweight Maintains
2024-05-30 Goldman Sachs Buy Initiate
2024-04-03 Citigroup Buy Buy Maintains
2024-07-10 Citigroup Buy Buy Maintains
2024-07-02 Evercore ISI Group In-Line In-Line Maintains
2024-07-15 Morgan Stanley Equal-Weight Equal-Weight Maintains
2024-07-15 BTIG Buy Buy Maintains
2024-07-09 Piper Sandler Overweight Overweight Maintains
2024-07-16 Truist Securities Buy Buy Maintains
2025-07-23 Truist Securities Buy Buy Maintains
2024-10-11 JP Morgan Overweight Overweight Maintains
2025-07-23 Piper Sandler Overweight Overweight Reiterate
2025-07-23 UBS Neutral Neutral Maintains
2025-07-23 Wells Fargo Overweight Overweight Maintains
2025-07-23 RBC Capital Outperform Outperform Maintains
2024-07-18 Barclays Overweight Overweight Maintains
2024-08-02 Redburn Atlantic Neutral Buy Upgrade
2025-04-23 Piper Sandler Overweight Overweight Maintains
2025-04-23 Truist Securities Buy Buy Maintains
2025-04-23 RBC Capital Outperform Outperform Maintains
2025-04-23 Evercore ISI Group In-Line In-Line Maintains
2024-07-19 Morgan Stanley Equal-Weight Equal-Weight Maintains
2024-07-19 JP Morgan Overweight Overweight Maintains
2024-07-19 BTIG Buy Buy Maintains
2024-07-19 Truist Securities Buy Buy Maintains
2024-07-19 Stifel Buy Buy Maintains
2024-07-19 Evercore ISI Group In-Line In-Line Maintains
2024-07-19 Piper Sandler Overweight Overweight Maintains
2024-07-19 Baird Outperform Outperform Maintains
2025-04-23 Baird Outperform Outperform Maintains
2024-08-28 BTIG Buy Buy Maintains
2025-01-24 Wells Fargo Overweight Overweight Maintains
2025-01-24 Piper Sandler Overweight Overweight Reiterate
2025-01-24 Raymond James Outperform Outperform Maintains
2025-01-24 Truist Securities Buy Buy Maintains
2025-01-24 Citigroup Buy Buy Maintains
2025-01-24 JP Morgan Overweight Overweight Maintains
2024-12-18 Truist Securities Buy Buy Maintains
2024-11-26 BTIG Buy Buy Maintains
2024-10-08 RBC Capital Outperform Outperform Maintains
2024-10-18 Baird Outperform Outperform Maintains
2024-08-22 Citigroup Buy Buy Maintains
2024-07-23 Barclays Overweight Overweight Maintains
2024-12-02 Morgan Stanley Equal-Weight Overweight Upgrade
2024-12-05 Stifel Buy Buy Maintains
2025-03-18 Baird Outperform Outperform Maintains
2024-10-18 BTIG Buy Buy Maintains
2024-10-18 Evercore ISI Group In-Line In-Line Maintains
2024-10-18 Piper Sandler Overweight Overweight Reiterate
2024-10-18 Stifel Buy Buy Maintains
2024-10-18 RBC Capital Outperform Outperform Maintains
2024-10-18 Wells Fargo Overweight Overweight Maintains
2025-04-24 Barclays Overweight Overweight Maintains
2025-03-17 Truist Securities Buy Buy Maintains
2024-10-14 BTIG Buy Buy Maintains
2024-10-14 Raymond James Outperform Outperform Maintains
2024-10-14 Truist Securities Buy Buy Maintains
2024-11-19 Erste Group Hold Buy Upgrade
2024-10-01 Evercore ISI Group In-Line In-Line Maintains
2024-12-11 Wells Fargo Overweight Overweight Maintains
2024-12-11 Citigroup Buy Buy Maintains
2025-08-19 RBC Capital Outperform Outperform Reiterate
2025-05-22 Citigroup Buy Buy Maintains
2025-06-09 Deutsche Bank Hold Sell Downgrade
2025-07-08 Evercore ISI Group In-Line In-Line Maintains
2025-07-23 BTIG Buy Buy Maintains
Revenue Estimates

The forecasted annual revenue of Intuitive Surgical, Inc. in 2031-12-31 is 15,859MM. )

Understanding a company’s revenue history gives investors a snapshot of its potential growth. Revenue growth is a solid predictor of earnings (or profit) growth. A company that can increase its revenue while keeping its operating costs constant has more available capital to reinvest into its business or return to shareholders through dividends or share buybacks.

However, investors should be careful before investing in a company that is growing revenue but showing declining earnings or is unprofitable. In some cases, this is simply a case of a young company that is still in an early growth phase. But if this is a mature company, it can indicate that other fundamental problems exist.

How to Interpret Revenue Estimates?

Fintel gives you revenue projections for stocks that cover 10 years between 2020 and 2030. Although past performance does not guarantee future results, you can be more confident in your decision to buy or sell a stock when you see a company with revenue that has a track record of increasing its revenue.

Update Frequency: Quarterly

Date Revenue Average Quarterly (MM) Number of Analysts (Quarterly) Revenue Average Annually (MM) Number of Analysts (Annually)
2025-09-30 2,305 3 -- --
2025-12-31 2,495 3 8,623 15
2026-03-31 2,514 3 -- --
2026-06-30 2,722 3 -- --
2026-09-30 2,665 3 -- --
2026-12-31 2,868 3 8,826 15
2027-12-31 -- -- 11,311 5
2028-12-31 -- -- 12,478 4
2029-12-31 -- -- 14,071 4
2030-12-31 -- -- 13,584 3
2031-12-31 -- -- 15,859 3
Earnings Estimates

The forecasted annual earnings of Intuitive Surgical, Inc. in 2032-12-31 is 19.59 per share.

One part of an analyst’s rating is a profit (i.e., earnings) estimate for the current quarter and/or future quarters. The measurement given is earnings per share (EPS). EPS is a metric that indicates how much a company earned as represented by one share of its stock over a specific period (typically three months).

Earnings per Share Calculation

To understand the earnings per share calculation, you must understand net income. Net income is the amount of money a company has left over after deducting appropriate expenses and taxes from its revenues).

The formula for earnings per share is net income divided by the total number of outstanding shares (i.e., available for purchase). For example:

Company A has a net income of $100 million and forty million outstanding shares. The EPS calculation is as follows:

100,000,000/40,000,000 = $2.50 per share

How to use Earnings Per Share in Stock Analysis

Earnings per share is an essential metric for you to consider when deciding to buy a stock. After all, a company with high earnings per share is productive and generates revenue in excess of its operating costs.

However, it’s not the only metric you should use. Metrics like price-to-earnings and debt-to-equity add additional perspective about a company’s health.

You should also be sure to compare a company’s EPS with a company in its sector. However, when you do, be aware that EPS is different and more important than net profit by itself. You may see a company that has a rising net profit. But if its outstanding shares are also rising, then its EPS might be flat or even edging lower.

Update Frequency: Quarterly

Date EPS Average (Quarterly) Number of Analysts (Quarterly) EPS Average (Annual) Number of Analysts (Annually)
2025-09-30 1.88 3 -- --
2025-12-31 1.98 3 7.48 18
2026-03-31 2.01 3 -- --
2026-06-30 2.18 3 -- --
2026-09-30 2.14 3 -- --
2026-12-31 2.34 3 8.72 18
2027-03-31 2.75 3 -- --
2027-06-30 2.96 3 -- --
2027-09-30 3.02 3 -- --
2027-12-31 3.43 3 10.22 5
2028-12-31 -- -- 12.11 3
2029-12-31 -- -- 13.84 3
2030-12-31 -- -- 17.26 3
2031-12-31 -- -- 18.07 3
2032-12-31 -- -- 19.59 3
EBITDA Estimates

The forecasted annual EBITDA of Intuitive Surgical, Inc. in 2028-12-31 is 5,918MM.

EBIDTA is an acronym that stands for earnings before interest, taxes, depreciation, and amortization. Analysts and investors pay attention to EBITDA because it strips out items that a company must report on its balance sheet but doesn’t significantly impact its business. Here’s an explanation of what that means for each part of the acronym:

Interest: Loan interest and earnings are subject to change based on a company’s financial strategy and, in any event, are not part of its core activities.

Taxes: Taxes are affected by governmental policy that can distort a company’s perceived profitability.

Depreciation: This accounts for the expected depreciation on tangible assets and immaterial goods from company investments. But since these investments may ultimately increase a company’s efficiency and profit potential, they aren’t a good indicator of a company’s current profitability.

Amortization: This shows the gradual writing off of the initial cost of an asset. It differs from depreciation because it is typically used with intangible assets such as intellectual property (e.g., patents, copyrights, etc.)

EBITDA vs. Net Income

Net income is the profit a company has left over after covering its operating expenses. However, net income includes the items that EBITDA excludes. That’s why most analysts prefer EBITDA because it better reflects the health of a company’s core business.

Update Frequency: Quarterly

Date EBITDA Average (MM Quarterly) Number of Analysts (Quarterly) EBITDA Average (MM Annually) Number of Analysts (Annually)
2025-09-30
2025-12-31
2026-03-31
2026-06-30
2026-09-30
2026-12-31
2027-12-31
2028-12-31
EBIT Estimates

The forecasted annual EBIT of Intuitive Surgical, Inc. in 2028-12-31 is 5,171MM.

EBIT is an acronym that stands for earnings before interest and taxes. Analysts use EBIT to measure a company’s performance because it strips out tax expenses and the costs of the capital structure influencing profit. These don’t significantly impact a company’s business.

Interest: Loan interest and earnings are subject to change based on a company’s financial strategy and, in any event, are not part of its core activities.

Taxes: Taxes are affected by governmental policy that can distort a company’s perceived profitability.

NOTE: EBIT is sometimes synonymous with operating income. However, in some cases, operating income doesn’t include gains or losses from non-core activities.

EBIT vs. EBITDA

EBITDA also strips out depreciation and amortization from a company’s earnings:

Depreciation: This accounts for the expected depreciation on tangible assets and immaterial goods from company investments. But since these investments may ultimately increase a company’s efficiency and profit potential, they aren’t a good indicator of a company’s current profitability.

Amortization: This shows the gradual writing off of the initial cost of an asset. It differs from depreciation because it is typically used with intangible assets such as intellectual property (e.g., patents, copyrights, etc.)

Update Frequency: Quarterly

Date EBIT Average (MM Quarterly) Number of Analysts (Quarterly) EBIT Average (MM Annually) Number of Analysts (Annually)
2025-09-30
2025-12-31
2026-03-31
2026-06-30
2026-09-30
2026-12-31
2027-12-31
2028-12-31
Other Listings
MX:ISRG
IT:1ISRG €387.80
GB:0R29 $464.10
CH:ISRG
DE:IUI1 €393.45
AT:ISRG
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista